Oral absorption of anti- AIDS nucleoside
✍
Patrick J. Sinko; John P. Sutyak; Glen D. Leesman; Peidi Hu; Vijaya D. Makhey; H
📂
Article
📅
1997
🏛
John Wiley and Sons
🌐
English
⚖ 389 KB
The absolute oral and regional intestinal bioavailabilities (BAs) and pharmacokinetics (PK) of 2 H , 3 H -dideoxyinosine (ddI), a nucleoside analog used in the treatment of human immunode®ciency virus (HIV) infection, were investigated in an in vivo intestinal± vascular access port (IVAP) dog model.